A comparative survey of functional footprints of EGFR pathway mutations in human cancers

Oncogene

Volumn 33, Issue 43, 2014, Pages 5078-5089

  Lane, A ^a   Segura Cabrera, A ^a   Komurov, K ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

EGFR oncogenes; functional footprints; oncogenic networks

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN;

ANTIBODY SPECIFICITY; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMIC INSTABILITY; HUMAN; INFLAMMATION; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MUTATION; NEOPLASMS; ORGAN SPECIFICITY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MICROENVIRONMENT;

EID: 85027922582     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.452     Document Type: Article

References (46)

1. Oda K, Matsuoka Y, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005; 1: 0010. DOI: 10.1038/msb4100014
2. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127–137. DOI: 10.1038/35052073
3. De Luca A, Maiello MR, D’Alessio A, Pergameno M, Normanno N. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 2012; 16 (Suppl 2): S17–S27. DOI: 10.1517/14728222.2011.639361
4. Ciardiello F, De Vita F, Orditura M, Tortora G. The role of EGFR inhibitors in nonsmall cell lung cancer. Curr Opin Oncol 2004; 16: 130–135. DOI: 10.1097/00001622-200403000-00008
5. Salama AK, Flaherty KT. BRAF in melanoma: current strategies and future directions. Clin Cancer Res 2013; 19: 4326–4334. DOI: 10.1158/1078-0432.CCR-13-0779
6. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9: 517–531. DOI: 10.1038/nrm2438
7. Pearson G, Bumeister R, Henry DO, Cobb MH, White MA. Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. J Biol Chem 2000; 275: 37303–37306. DOI: 10.1074/jbc.C000570200
8. Parekh DB, Katso RM, Leslie NR, Downes CP, Procyk KJ, Waterfield MD et al. Beta1-integrin and PTEN control the phosphorylation of protein kinase C. Biochem J 2000; 352 (Pt 2): 425–433. DOI: 10.1042/bj3520425
9. Vincent EE, Elder DJ, Thomas EC, Phillips L, Morgan C, Pawade J et al. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer 2011; 104: 1755–1761. DOI: 10.1038/bjc.2011.132
10. Gallay N, Dos Santos C, Cuzin L, Bousquet M, Simmonet Gouy V, Chaussade C et al. The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia. Leukemia 2009; 23: 1029–1038. DOI: 10.1038/leu.2008.395
11. Uribe P, Andrade L, Gonzalez S. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. J Invest Dermatol 2006; 126: 161–166. DOI: 10.1038/sj.jid.5700011
12. Hegi ME, Diserens AC, Bady P, Kamoshima Y, Kouwenhoven MC, Delorenzi M et al. Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib—a phase II trial. Mol Cancer Ther 2011; 10: 1102–1112. DOI: 10.1158/1535-7163.MCT-11-0048
13. Komurov K, White MA, Ram PT. Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data. PLoS Comput Biol 2010; 6: e1000889. DOI: 10.1371/journal.pcbi.1000889
14. Komurov K, Dursun S, Erdin S, Ram PT. NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics 2012; 13: 282. DOI: 10.1186/1471-2164-13-282
15. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149: 274–293. DOI: 10.1016/j.cell.2012.03.017
16. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005; 207: 145–157. DOI: 10.1111/j.0105-2896.2005.00316.x
17. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol 2008; 8: 607–618. DOI: 10.1038/nri2368
18. Wolpert F, Roth P, Lamszus K, Tabatabai G, Weller M, Eisele G. HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells. J Neuroimmunol 2012; 250: 27–34. DOI: 10.1016/j.jneuroim.2012.05.010
19. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012; 483: 570–575. DOI: 10.1038/nature11005
20. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603–607. DOI: 10.1038/nature11003
21. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515–527. DOI: 10.1016/j.ccr.2006.10.008
22. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98–110. DOI: 10.1016/j.ccr.2009.12.020
23. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008; 452: 429–435. DOI: 10.1038/nature06757
24. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton HC et al. An integrated approach to uncover drivers of cancer. Cell 2010; 143: 1005–1017. DOI: 10.1016/j.cell.2010.11.013
25. Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 2003; 34: 166–176. DOI: 10.1038/ng1165
26. Fukuoka M, Wu YL, Thongprasert S, Sunpaweravong P, Leong SS, Sriuranpong V et al. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol 2011; 29: 2866–2874. DOI: 10.1200/JCO.2010.33.4235
27. Dahabreh IJ, Linardou H, Siannis F, Kosmidis P, Bafaloukos D, Murray S. Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res 2010; 16: 291–303. DOI: 10.1158/1078-0432.CCR-09-1660
28. Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F et al. Targeting EGFR in pancreatic cancer treatment. Curr Drug Targets 2012; 13: 802–810. DOI: 10.2174/138945012800564158
29. Taylor TE, Furnari FB, Cavenee WK. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets 2012; 12: 197–209. DOI: 10.2174/156800912799277557
30. Saxena R, Dwivedi A. ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective. Med Res Rev 2010; 32: 166–215. DOI: 10.1002/med.20209
31. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science 2013; 339: 1546–1558. DOI: 10.1126/science.1235122
32. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164. DOI: 10.1093/nar/gkq603
33. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P et al. Human protein reference database—2006 update. Nucleic Acids Res 2006; 34 (Database issue): D411–D414. DOI: 10.1093/nar/gkj141
34. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L et al. MINT: the molecular INTeraction database. Nucleic Acids Res 2007; 35 (Database issue): D572–D574. DOI: 10.1093/nar/gkl950
35. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 2005; 33 (Database issue): D428–D432. DOI: 10.1093/nar/gki072
36. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW. BIND—the biomolecular interaction network database. Nucleic Acids Res 2001; 29: 242–245. DOI: 10.1093/nar/29.1.242
37. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M et al. The BioGRID interaction database: 2008 update. Nucleic Acids Res 2008; 36 (Database issue): D637–D640.
38. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res 2011; 39 (Database issue): D685–D690. DOI: 10.1093/nar/gkq1039
39. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000; 28: 316–319. DOI: 10.1093/nar/28.1.316
40. Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, Aerts S et al. ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res 2008; 36 (Database issue): D107–D113.
41. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489: 91–100. DOI: 10.1038/nature11245
42. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011; 27: 1739–1740. DOI: 10.1093/bioinformatics/btr260
43. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009; 37 (Database issue): D603–D610. DOI: 10.1093/nar/gkn810
44. Schellenberger J, Park JO, Conrad TM, Palsson BO. BiGG: a biochemical genetic and genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics 2010; 11: 213. DOI: 10.1186/1471-2105-11-213
45. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27–30. DOI: 10.1093/nar/28.1.27
46. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2007; 35 (Database issue): D26–D31. DOI: 10.1093/nar/gkl993